Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna EllaBhaswati Guha Majumder Monday, November 29, 2021 06:23 PM IST
What Can Possibly Explain WHO's Delay In Approving Covaxin?Bhaswati Guha Majumder Wednesday, October 20, 2021 07:16 PM IST
ZyCoV-D: India's Homegrown Three-Dose Covid-19 Vaccine For Anyone Over 12, Approved For Emergency UseKaran KambleSaturday, August 21, 2021 05:14 AM IST
Bharat Biotech's Krishna Ella Says Company Working On A Combo Of Covaxin And Nasal Vaccine For Booster DoseBhaswati Guha Majumder Monday, August 16, 2021 05:01 PM IST
What We Know About Union Health Minister's Meeting With WHO Chief ScientistBhaswati Guha Majumder Saturday, August 14, 2021 05:01 PM IST
Ahmedabad Based Zydus Cadila Seeks DCGI Nod For Phase-3 Clinical Trials Of Its COVID-19 Vaccine With 30,000 VolunteersSwarajya StaffFriday, December 25, 2020 09:32 AM IST